Medicine and Dentistry
Sputum
100%
Cystic Fibrosis
83%
Patient
82%
Lung
77%
Therapeutic Procedure
47%
Microbiome
46%
Ivacaftor
42%
Culture
31%
Reflux
30%
Pseudomonas aeruginosa
27%
Bronchiectasis
27%
Bacterium
23%
Azithromycin
22%
Neutrophil
22%
Tissues
22%
Real-Time Polymerase Chain Reaction
21%
Chronic Obstructive Pulmonary Disease
20%
Levofloxacin
20%
In Vitro
20%
Inpatient
20%
RNA 16S
19%
Combination Therapy
17%
Chest
17%
Serositis
16%
Organism
15%
Disease Severity
15%
Development
15%
Marker
15%
Treatment Response
15%
Analysis
15%
Randomized Controlled Trial
14%
Infection
14%
Computed Tomography
14%
Gastroesophageal Reflux
13%
Adult
13%
Lower Respiratory Tract
13%
Upper Respiratory Tract
13%
Anti-biotics
12%
Low Drug Dose
12%
Proteomics
12%
Allograft
12%
Extracellular Trap
11%
Epstein Barr Virus
11%
Volunteer
11%
Streptococcus
11%
Community Structure
10%
Patient with Cystic Fibrosis
10%
Evolution
10%
Cystic Fibrosis Transmembrane Conductance Regulator
10%
Mucus
9%
Immunology and Microbiology
Lung
86%
Sputum
83%
Sample
61%
Microflora
61%
Microbiome
38%
Taxon
32%
Pseudomonas
29%
Bacterium
20%
Mannose Binding Lectin
20%
Illumina MiSeq
20%
Inflammation
18%
Streptococcus
17%
Health
17%
Tissues
16%
Genus
16%
Anaerobic Bacterium
15%
Prevotella
14%
Veillonella
14%
Computer Assisted Tomography
13%
Haemophilus
12%
Neutrophil Extracellular Traps
11%
Epstein Barr Virus
11%
Anaerobe
11%
Reduction (Chemistry)
10%
Development
10%
Pseudomonas aeruginosa
10%
Western Blot
10%
Restriction Fragment Length Polymorphism
10%
Haplotype
10%
Time
10%
Mortality
9%
Infectious Agent
8%
Mutation
8%
Real-Time Polymerase Chain Reaction
8%
Common Variable Immunodeficiency
7%
Aerobic Bacterium
7%
Mucus
7%
Allotransplantation
6%
Age
6%
Electric Potential
6%
Prevalence
6%
Marker Gene
5%
Comprehension
5%
Propionibacterium acnes
5%
B Cell
5%
Resistin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
53%
Pseudomonas aeruginosa
34%
Bacterium
31%
Infection
24%
Bronchiectasis
20%
Levofloxacin
20%
Microbiome
18%
Antibiotics
18%
Antibiotic Agent
13%
Clinical Trial
12%
Tamsulosin
12%
Pseudomonas Infection
12%
Infectious Agent
11%
Respiratory Tract
10%
Cigarette Smoke
10%
Chronic Obstructive Lung Disease
10%
Streptococcus
9%
Virulence
8%
Diseases
8%
Gentamicin
8%
Prevotella
7%
Veillonella
7%
Antiinfective Agent
7%
Respiratory Tract Infection
7%
Protein
6%
Cement
6%
Cefuroxime
6%
Propionibacterium acnes
6%
Staphylococcus
6%
Microflora
5%
Resistin
5%
Electronic Cigarette
5%
Burkholderia Cepacia Complex
5%
